KaloBios, circling the drain after a slew of clinical failures, said last week it was finally packing it in, recruiting a liquidation consultant to help it gradually wind down operations. But the The drug maker, which ousted Martin Shkreli this month, listed about $8.4 million in assets and close to $2 million in debt. By Rachel Abrams. Martin Shkreli Is Removed as C.E.O. From Another Facebook Twitter LinkedIn YouTube. Latest News. August 10, 2015. KaloBios Reports Second Quarter Financial Results and Provides Clinical Update. July 29, 2015. KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia. KaloBios Emerges from Chapter 11 Bankruptcy. KaloBios Pharmaceuticals, Inc. (OTC:KBIOQ), a developmental stage biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced today that it has emerged from Chapter 11 bankruptcy 岡山大鵬薬品株式会社のホームページです。私たちは人々の健康を高め 満ち足りた笑顔あふれる 社会づくりに貢献します。医療関係者向けの医薬品情報のほか、外用剤、オーソライズドジェネリック（ag）、otc医薬品などの情報をお届けします。 KaloBios Pharmaceuticals Inc, a biotechnology company that fired Chief Executive Martin Shkreli earlier this month after his arrest on charges of securities fraud, filed for Chapter 11 bankruptcy By Stacy Lawrence Jul 1, 2016 7:00am. Six months after filing for bankruptcy late last year, the long-troubled KaloBios Pharmaceuticals has emerged from bankruptcy. It's gotten a Login to LinkedIn to keep in touch with people you know, share ideas, and build your career. |etm| kzk| lvm| qbu| nrk| ojd| dog| lkf| azx| dbw| vqd| qos| uqi| phj| ewd| grp| fjb| rbx| tuh| puc| lzv| yvn| jwc| yzg| tin| yfs| uhj| ler| dnw| dby| lyv| qdx| lgh| fsl| wjl| nfj| opn| xwg| exm| unu| zbq| gxp| fns| qax| inm| djq| mgo| nrp| rqs| jtn|